BellBrook Labs

Bell Brook Labs

Biotechnology, 5500 Nobel Dr Ste 230, Madison, Wisconsin, 53711, United States, 11-50 Employees

bellbrooklabs.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 60********

Who is BELLBROOK LABS

BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company,...

Read More

map
  • 5500 Nobel Dr Ste 230, Madison, Wisconsin, 53711, United States Headquarters: 5500 Nobel Dr Ste 230, Madison, Wisconsin, 53711, United States
  • 2002 Date Founded: 2002
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 3826

checked-icon Does something look wrong? Fix it. | View contact records from BELLBROOK LABS

BellBrook Labs Org Chart and Mapping

Employees

Ha Pham

Senior Scientist, Assay Development

Justin Brink

Chief Operating Officer

Siddharth Tripathi

Senior Scientist, Discovery Services

Thane Westermeyer

Senior Research Chemist 1

Abby Boswell

Marketing Coordinator I

Traci Pretsch

Chief Financial Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BellBrook Labs

Answer: BellBrook Labs's headquarters are located at 5500 Nobel Dr Ste 230, Madison, Wisconsin, 53711, United States

Answer: BellBrook Labs's phone number is 60********

Answer: BellBrook Labs's official website is https://bellbrooklabs.com

Answer: BellBrook Labs's revenue is $10 Million to $25 Million

Answer: BellBrook Labs's SIC: 3826

Answer: BellBrook Labs has 11-50 employees

Answer: BellBrook Labs is in Biotechnology

Answer: BellBrook Labs contact info: Phone number: 60******** Website: https://bellbrooklabs.com

Answer: BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company, we identify areas where there is a strong need but a significant technical hurdle, and then we develop a solution. Transcreener Biochemical Assay Technology: Our proprietary Transcreener HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. It relies on homogenous fluorescent immunodetection of nucleotides, including ADP, UDP, GDP, AMP and GMP, that are formed by thousands of cellular enzymes. Among these are group transferase families, such as kinases and glycosyltransferases, that catalyze the covalent regulatory reactions that are central to cell signaling. Each Transcreener Assay provides a generic detection method for multiple enzyme families. This means that you can focus on evaluating new therapeutic strategies and optimizing lead molecules rather than on time-consuming assay development for individual targets. The platform has been rapidly validated and adopted by pharmaceutical and biotechnology screening labs around the world.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access